Sort
17,828 grants matching “crispr”
PROMINENT-DUKE
$228,578Christopher M Counter · Duke University · OT2 · FY2022 · CA
Defining and targeting ER quality control dependence in rhabdomyosarcoma
$228,570Amit J. Sabnis · University Of California, San Francisco · K08 · FY2020 · CA
Elucidating the function of a family of respiratory viral long noncoding RNAs
$228,535Christopher S. Sullivan · University Of Texas At Austin · R21 · FY2020 · AI
Biophysical and Mechanistic Determinants for Cancer Cell Import of Hydrocarbon-Stapled Peptides
$228,375Loren D Walensky · Dana-Farber Cancer Inst · R21 · FY2017 · CA
Project 3: Repurposing Ceritinib for Ovarian Cancer Therapy
$228,197Larry M Karnitz · Mayo Clinic Rochester · P50 · FY2025 · CA
Examining the role of IP6 in HIV-1 replication
$228,144Marc C Johnson · University Of Missouri-Columbia · R21 · FY2020 · AI
From 3D genomes to neural connectomes: Higher-order chromatin mechanisms encoding long-term memory
$228,058Jennifer Elizabeth Phillips-Cremins · University Of Pennsylvania · DP1 · FY2025 · MH
Bone Cells and Signaling Core
$228,015Paola Pajevic Divieti · Massachusetts General Hospital · P30 · FY2018 · AR
USING CELL, FLY, AND ZEBRAFISH MODELS TO UNDERSTAND FAM109A GENE FUNCTION IN UNDIAGNOSED DISEASE
$228,000Yuchin Albert Pan · Augusta University · R21 · FY2016 · GM
Role of TREM2 in host defense and immunity during infection
$228,000Melissa Bruckner Lodoen · University Of California-Irvine · R21 · FY2024 · AI
CRISPRi-based discovery and in vivo validation of drug targets in M. abscessus
$228,000Kyle H Rohde · University Of Central Florida · R21 · FY2021 · AI
Liposome fusion enabled extracellular vesicle detection for COVID-19
$228,000Bo Ning · Tulane University Of Louisiana · R21 · FY2022 · AI
USING CELL, FLY, AND ZEBRAFISH MODELS TO UNDERSTAND FAM109A GENE FUNCTION IN UNDIAGNOSED DISEASE
$228,000Graydon Gonsalvez · Augusta University · R21 · FY2017 · GM
Drug susceptibilities in fusion oncogene-driven pediatric sarcomas
$227,984Irwin H. Gelman · Roswell Park Cancer Institute Corp · R21 · FY2019 · CA
IGF2 regulation of microglia and synaptic function during aging
$227,921Timothy Joseph Jarome · Virginia Polytechnic Inst And St Univ · R21 · FY2023 · AG
Microbial Genomics Biomedical Core
$227,850Anne-Catrin Uhlemann · Columbia University Health Sciences · U54 · FY2021 · DK
Identification of the protein:protein interactions of a non-nuclear NFKB that modulates ethanol sensitivity.
$227,844Nigel S Atkinson · University Of Texas At Austin · R21 · FY2024 · AA
Viral gene drive as a novel curative therapy for HSV infection
$227,635Marius Walter · Fred Hutchinson Cancer Center · R21 · FY2024 · AI
Role for novel ventral tegmental area neuromedin S neurons in morphine responses
$227,595Michelle Suzanne Mazei-Robison · Michigan State University · R21 · FY2023 · DA
Engineering of glycosyltransferases to obtain glycan binding proteins
$227,561Sheldon Park · State University Of New York At Buffalo · R21 · FY2020 · GM
Determination of chromatin protein dynamics in CD8 T cells
$227,500Yongqiang Feng · St. Jude Children'S Research Hospital · R21 · FY2024 · AI
The non-canonical role of the CRISPR Cas2 nuclease in infection by Legionella pneumophila
$227,370Nicholas Philip Cianciotto · Northwestern University At Chicago · R21 · FY2017 · AI
Determinants of Persistence in Epigenetic Editing
$227,309David J Segal · University Of California At Davis · R21 · FY2019 · HG
Targeting ferroptosis in aggressive subtypes of lung cancer
$227,210Triparna Sen · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA
Clonal drivers of resistance to immune checkpoint blockade in liver malignancies
$227,205Giannicola Genovese · University Of Tx Md Anderson Can Ctr · R21 · FY2022 · CA